Missed rifampicin and isoniazid resistance by commercial molecular assays
Drug-resistant tuberculosis (TB) has poor outcomes unless resistance is detected early, ideally by commercially available molecular tests. We present a case of occult multidrug-resistant TB where both rifampicin and isoniazid resistance were missed by molecular testing and were only identified...
Saved in:
| Main Authors: | L Richards, F Ismail, J Nel, S V Omar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
South African Medical Association
2024-07-01
|
| Series: | South African Medical Journal |
| Subjects: | |
| Online Access: | https://samajournals.co.za/index.php/samj/article/view/1779 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isoniazid-resistant TB and associated factors in Ethiopia
by: S. Moga, et al.
Published: (2025-06-01) -
Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01) -
Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01) -
Analysis of Fungi in the Respiratory Tract of Patients with Tuberculosis at the Palembang Public Health Laboratory Center (BBLKM Palembang)
by: Herry Hermansyah, et al.
Published: (2024-12-01) -
Utility of stool Xpert MTB/Rif assay in the diagnosis of pulmonary and abdominal tuberculosis in children - A study from Western India
by: Ira Shah, et al.
Published: (2025-03-01)